Stokes Family Office’s iShares iBonds Dec 2030 Term Corporate ETF IBDV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$638K Buy
29,250
+5,405
+23% +$118K 0.07% 170
2026
Q1
$522K Hold
23,845
0.05% 181
2025
Q4
$526K Hold
23,845
0.05% 186
2025
Q3
$528K Hold
23,845
0.05% 172
2025
Q2
$524K Hold
23,845
0.06% 160
2025
Q1
$518K Hold
23,845
0.06% 154
2024
Q4
$509K Hold
23,845
0.05% 161
2024
Q3
$529K Hold
23,845
0.06% 146
2024
Q2
$507K Buy
23,845
+1,500
+7% +$31.7K 0.06% 150
2024
Q1
$478K Buy
22,345
+2,000
+10% +$42.8K 0.06% 149
2023
Q4
$440K Buy
+20,345
New +$421K 0.06% 149

Other funds holding IBDV

Stokes Family Office's IBDV Position: Q2 2026 in Review

Stokes Family Office increased its iShares iBonds Dec 2030 Term Corporate ETF (IBDV) stake by 23% in Q2 2026, buying an estimated $118K and bringing the position to 29,250 shares worth $638K. The position accounts for 0.07% of the portfolio, ranked #170.

Stokes Family Office first reported a position in IBDV in Q4 2023 and has held it in 11 quarters since. 350 funds tracked by Wall St. Rank hold IBDV as of Q2 2026.

  • Stokes Family Office held 29,250 shares of iShares iBonds Dec 2030 Term Corporate ETF worth $638K as of Q2 2026.
  • Stokes Family Office bought 5,405 iShares iBonds Dec 2030 Term Corporate ETF shares in Q2 2026, an estimated $118K.
  • iShares iBonds Dec 2030 Term Corporate ETF made up 0.07% of Stokes Family Office's portfolio in Q2 2026, its #170 holding.
  • Stokes Family Office first reported a position in iShares iBonds Dec 2030 Term Corporate ETF in Q4 2023 and has held it in 11 quarters since.
  • 350 funds tracked by Wall St. Rank held iShares iBonds Dec 2030 Term Corporate ETF as of Q2 2026.

Based on Stokes Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.